Skip to main content
Back to Insight Partners

Insight Partners's Biotechnology Portfolio

Browse 5 Biotechnology companies funded by Insight Partners. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
5
Total Funding in Biotechnology
$271.7M

Biotechnology Portfolio Companies (5)

Export
BiotechnologyHealth CareInformation Technology

ImmuneBridge is developing allogeneic immunotherapies for cancer.

San Francisco, United States
March 2026
$7.7M
Seed

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsLife Science

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

New York, United States
August 2025
$44.0M
Series C

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical

Proscia develops digital pathology software designed to help laboratories and life sciences organizations manage and analyze pathology data.

Philadelphia, United States
March 2025
$50.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

San Diego, United States
September 2024
$50.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

Boston, United States
September 2024
$120.0M
Series A

Founder Contacts

19,000+ verified contacts

Explore Insight Partners's Full Portfolio

View all companies funded by Insight Partners across every industry and funding stage.

View Full Insight Partners Portfolio